Werkgroep Cardiologische centra Nederland

SYNCHRONIZE-CVOT (Follow-up)

A Phase III, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity
Medicine
BI 456906
Population
ASCVD
Phase
III
Starting year
2022

Director of Study

dr. H.J. Houtgraaf (Cardioloog)
Utrecht, Diakonessenhuis